LoginRegister
    Cipla to acquire 26 percent stake in AMP Solar Power SystemsCipla to acquire 26 percent stake in AMP Solar Power Systems
    Torrent Pharma posts Q4 net loss of Rs 152 croreTorrent Pharma posts Q4 net loss of Rs 152 crore
    China M&A crimp due to data quality, lagging regulatory standards; says Novartis CEOChina M&A crimp due to data quality, lagging regulatory standards; says Novartis CEO
    Fortis investors move SEBI over delay in IHH open offer, ask for interest: ReportFortis investors move SEBI over delay in IHH open offer, ask for interest: Report
    Zydus Cadila gets USFDA approval for Esomeprazole Magnesium delayed-release capsulesZydus Cadila gets USFDA approval for Esomeprazole Magnesium delayed-release capsules
    Biocon, Mylan gets Canadian nod for biosimilar of cancer drug HerceptinBiocon, Mylan gets Canadian nod for biosimilar of cancer drug Herceptin
    Cipla Q4 net profit jumps 133 pc at Rs 357.68 crore; plans fundraising of Rs 6000 croreCipla Q4 net profit jumps 133 pc at Rs 357.68 crore; plans fundraising of Rs 6000 crore
    Novartis plans gene therapy price lower than $4 million to $5 million rangeNovartis plans gene therapy price lower than $4 million to $5 million range
    CDSCO rejects GSK request to skip Phase III trial for Influenza Vaccine for higher age groupsCDSCO rejects GSK request to skip Phase III trial for Influenza Vaccine for higher age groups
    Medtronic says wont recall pacemakers in India; in discussion with CDSCOMedtronic says won't recall pacemakers in India; in discussion with CDSCO
    Panacea Biotec gets USFDA nod for chemotherapy drug AzacitidinePanacea Biotec gets USFDA nod for chemotherapy drug Azacitidine
    Varian to acquire Cancer Treatment Services International for Rs 1980 croreVarian to acquire Cancer Treatment Services International for Rs 1980 crore
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X